OCT Analysis of Retinal Pigment Epithelium in Myopic Choroidal Neovascularization: Correlation Analysis with Different Treatments
Abstract
:1. Introduction
2. Materials and Methods
2.1. Study Design and Population
2.2. Patient’s Examination
2.3. Scan Analysis
2.4. Statistical Analysis
3. Results
3.1. Study Population
3.2. Eye Treatments
4. Discussion
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Wang, N.-K.; Lai, C.-C.; Chou, C.L.; Chen, Y.-P.; Chuang, L.-H.; Chao, A.-N.; Tseng, H.-J.; Chang, C.-J.; Wu, W.-C.; Chen, K.-J.; et al. Choroidal Thickness and Biometric Markers for the Screening of Lacquer Cracks in Patients with High Myopia. PLoS ONE 2013, 8, e53660. [Google Scholar]
- Curtin, B.J.; Karlin, D.B. Axial length measurements and fundus changes of the myopic eye. I. The posterior fundus. Trans. Am. Ophthalmol. Soc. 1970, 68, 312–334. [Google Scholar] [PubMed]
- Yoshida, T.; Ohno-Matsui, K.; Yasuzumi, K.; Kojima, A.; Shimada, N.; Futagami, S.; Tokoro, T.; Mochizuki, M. Myopic choroidal neovascularization: A 10-year follow-up. Ophthalmology 2003, 110, 1297–1305. [Google Scholar] [CrossRef]
- Grossniklaus, H.E.; Green, W.R. Pathologic findings in pathologic myopia. Retina 1992, 12, 127–133. [Google Scholar] [CrossRef]
- Teeters, V.W.; Bird, A.C. A clinical study of the vascularity of senile disciform macular degeneration. Am. J. Ophthalmol. 1973, 75, 53–65. [Google Scholar] [CrossRef]
- Gass, J.D. Biomicroscopic and histopathologic considerations regarding the feasibility of surgical excision of subfoveal neovascular membranes. Am. J. Ophthalmol. 1994, 118, 285–298. [Google Scholar] [CrossRef]
- Gass, J.D. Pathogenesis of disciform detachment of the neuroepithelium. Am. J. Ophthalmol. 1967, 63, 1–139. [Google Scholar]
- Ryan, S.J. Subretinal neovascularization. Natural history of an experimental model. Arch. Ophthalmol. 1982, 100, 1804–1809. [Google Scholar] [CrossRef]
- Miller, H.; Miller, B.; Ryan, S.J. The role of retinal pigment epithelium in the involution of subretinal neovascularization. Investig. Ophthalmol. Vis. Sci. 1986, 27, 1644–1652. [Google Scholar]
- Margolis, R.; Mukkamala, S.K.; Jampol, L.M.; Spaide, R.F.; Ober, M.D.; Sorenson, J.A.; Gentile, R.C.; Miller, J.A.; Sherman, J.; Freund, K.B. The expanded spectrum of focal choroidal excavation. Arch. Ophthalmol. 2011, 129, 1320–1325. [Google Scholar] [CrossRef]
- Haruta, M.; Hangai, M.; Taguchi, C.; Yamakawa, R. Spectral-domain optical coherence tomography of the choroid in choroidal osteoma. Ophthalmic Surg. Lasers Imaging Retina 2011, 42, e118-21. [Google Scholar] [CrossRef]
- Vance, S.K.; Khan, S.; Klancnik, J.M.; Freund, K.B. Characteristic spectral-domain optical coherence tomography findings of multifocal choroiditis. Retina 2011, 31, 717–723. [Google Scholar] [CrossRef]
- Freund, K.B.; Laud, K.; Lima, L.H.; Spaide, R.F.; Zweifel, S.; Yannuzzi, L.A. Acquired Vitelliform Lesions: Correlation of clinical findings and multiple imaging analyses. Retina 2011, 31, 13–25. [Google Scholar] [CrossRef] [Green Version]
- Yehoshua, Z.; Rosenfeld, P.J.; Gregori, G.; Penha, F. Spectral domain optical coherence tomography imaging of dry age-related macular degeneration. Ophthalmic Surg. Lasers Imaging Retina 2010, 41, S6–S14. [Google Scholar] [CrossRef]
- Khan, S.; Engelbert, M.; Imamura, Y.; Freund, K.B. Polypoidal choroidal vasculopathy: Simultaneous indocyanine green angiography and eye-tracked spectral domain optical coherence tomography findings. Retina 2012, 32, 1057–1068. [Google Scholar] [CrossRef]
- Sulzbacher, F.; Kiss, C.; Munk, M.; Deak, G.; Sacu, S.; Schmidt-Erfurth, U. Diagnostic evaluation of type 2 (classic) choroidal neovascularization: Optical coherence tomography, indocyanine green angiography, and fluorescein angiography. Am. J. Ophthalmol. 2011, 152, 799–806. [Google Scholar] [CrossRef]
- Giani, A.; Luiselli, C.; Esmaili, D.D.; Salvetti, P.; Cigada, M.; Miller, J.W.; Staurenghi, G. Spectral-domain optical coherence tomography as an indicator of fluorescein angiography leakage from choroidal neovascularization. Investig. Ophthalmol. Vis. Sci. 2011, 52, 5579–5586. [Google Scholar] [CrossRef]
- Golbaz, I.; Ahlers, C.; Stock, G.; Schütze, C.; Schriefl, S.; Schlanitz, F.; Simader, C.; Prünte, C.; Schmidt-Erfurth, U.M. Quantification of the therapeutic response of intraretinal, subretinal, and subpigment epithelial compartments in exudative AMD during anti-VEGF therapy. Investig. Ophthalmol. Vis. Sci. 2011, 52, 1599–1605. [Google Scholar] [CrossRef]
- Costagliola, C.; Semeraro, F.; dell’Omo, R.; Romano, M.R.; Russo, A.; Aceto, F.; Mastropasqua, R.; Porcellini, A. Effect of intravitreal ranibizumab injections on aqueous humour concentrations of vascular endothelial growth factor and pigment epithelium-derived factor in patients with myopic choroidal neovascularisation. Br. J. Ophthalmol. 2015, 99, 1004–1008. [Google Scholar] [CrossRef]
- Ding, X.; Zhan, Z.; Sun, L.; Yang, Y.; Li, S.; Zhang, A.; Luo, X.; Lu, L. Retinal pigmental epithelium elevation and external limiting membrane interruption in myopic choroidal neovascularization: Correlation with activity. Graefe’s Arch. Clin. Exp. Ophthalmol. 2018, 256, 1831–1837. [Google Scholar] [CrossRef]
- Verteporfin in Photodynamic Therapy (VIP) Study Group1234. Photodynamic therapy of subfoveal choroidal neovascularization in pathologic myopia with verteporfin: 1-year results of a randomized clinical trial—VIP report No. 1. Ophthalmology 2001, 108, 841–852. [Google Scholar] [CrossRef]
- Michels, S.; Schmidt-Erfurth, U. Sequence of Early Vascular Events after Photodynamic Therapy. Investig. Ophthalmol. Vis. Sci. 2003, 44, 2147–2154. [Google Scholar] [CrossRef] [PubMed]
- Wang, X.; Yang, J.; Liu, Y.; Yang, L.; Xia, H.; Ren, X.; Hou, Q.; Ge, Y.; Wang, C.; Li, X. Choroidal Morphologic and Vascular Features in Patients with Myopic Choroidal Neovascularization and Different Levels of Myopia Based on Image Binarization of Optical Coherence Tomography. Front. Med. 2022, 8, 791012. [Google Scholar] [CrossRef] [PubMed]
- Rinaldi, M.; Semeraro, F.; Chiosi, F.; Russo, A.; Romano, M.R.; Savastano, M.C.; dell’Omo, R.; Costagliola, C. Reduced-fluence verteporfin photodynamic therapy plus ranibizumab for choroidal neovascularization in pathologic myopia. Graefe’s Arch. Clin. Exp. Ophthalmol. 2017, 255, 529–539. [Google Scholar] [CrossRef]
- Parodi, M.B.; Da Pozzo, S.; Ravalico, G. Angiographic features after photodynamic therapy for choroidal neovascularisation in age related macular degeneration and pathological myopia. Br. J. Ophthalmol. 2003, 87, 177–183. [Google Scholar] [CrossRef]
- Schnurrbusch, U.E.; Welt, K.; Horn, L.C.; Wiedemann, P.; Wolf, S. Histological findings of surgically excised choroidal neovascular membranes after photodynamic therapy. Br. J. Ophthalmol. 2001, 85, 1086–1091. [Google Scholar] [CrossRef]
- Yoon, J.U.; Byun, Y.J.; Koh, H.J. Intravitreal anti-VEGF versus photodynamic therapy with verteporfin for treatment of myopic choroidal neovascularization. Retina 2010, 30, 418–424. [Google Scholar] [CrossRef]
- Ikuno, Y.; Nagai, Y.; Matsuda, S.; Arisawa, A.; Sho, K.; Oshita, T.; Takahashi, K.; Uchihori, Y.; Gomi, F. Two-year visual results for older Asian women treated with photodynamic therapy or bevacizumab for myopic choroidal neovascularization. Am. J. Ophthalmol. 2010, 149, 140–146. [Google Scholar] [CrossRef]
Group A # | Group B $ | p-Value | |
---|---|---|---|
N° of patients | 51 | 32 | - |
Female | 35 | 22 | 0.991 |
Age (years) | 66 (IQR 59–70) | 66 (IQR 57–71) | 0.949 |
N° of eyes (total, L, R) | 58 (26 L, 32 R) | 32 (14 L, 18 R) | - |
Lesion area (mm2) | 0.42 (0.30–1.01) | 1.60 (0.72–2.67) | <0.001 |
Major Ø (mm) | 0.76 (0.54–1.28) | 1.76 (1.13–2.23) | <0.001 |
Minor Ø (mm) | 0.47 (0.36–0.77) | 0.98 (0.65–1.23) | <0.001 |
N° of treatments | 3.67 ± 2.08 | 6.54 ± 2.82 | <0.010 |
Duration of therapy | 6.04 ± 8.5 | 17.2 ± 16.5 | <0.010 |
Time from the last treatment (months) | 29 (IQR 13–46) | 20 (IQR 10–33) | 0.302 |
Ring in infrared | 1 (1.72 %) | 7 (23.33 %) | <0.010 |
Ring in autofluorescence | 6 (10.34 %) | 12 (37.5 %) | <0.010 |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Allegrini, D.; Vezzola, D.; Borgia, A.; Raimondi, R.; Sorrentino, T.; Tripepi, D.; Stradiotto, E.; Alì, M.; Montesano, G.; Romano, M.R. OCT Analysis of Retinal Pigment Epithelium in Myopic Choroidal Neovascularization: Correlation Analysis with Different Treatments. J. Clin. Med. 2022, 11, 5023. https://doi.org/10.3390/jcm11175023
Allegrini D, Vezzola D, Borgia A, Raimondi R, Sorrentino T, Tripepi D, Stradiotto E, Alì M, Montesano G, Romano MR. OCT Analysis of Retinal Pigment Epithelium in Myopic Choroidal Neovascularization: Correlation Analysis with Different Treatments. Journal of Clinical Medicine. 2022; 11(17):5023. https://doi.org/10.3390/jcm11175023
Chicago/Turabian StyleAllegrini, Davide, Diego Vezzola, Alfredo Borgia, Raffaele Raimondi, Tania Sorrentino, Domenico Tripepi, Elisa Stradiotto, Marco Alì, Giovanni Montesano, and Mario R. Romano. 2022. "OCT Analysis of Retinal Pigment Epithelium in Myopic Choroidal Neovascularization: Correlation Analysis with Different Treatments" Journal of Clinical Medicine 11, no. 17: 5023. https://doi.org/10.3390/jcm11175023
APA StyleAllegrini, D., Vezzola, D., Borgia, A., Raimondi, R., Sorrentino, T., Tripepi, D., Stradiotto, E., Alì, M., Montesano, G., & Romano, M. R. (2022). OCT Analysis of Retinal Pigment Epithelium in Myopic Choroidal Neovascularization: Correlation Analysis with Different Treatments. Journal of Clinical Medicine, 11(17), 5023. https://doi.org/10.3390/jcm11175023